These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1370678)

  • 21. Heterogeneous reactivity with LH7.2 and the first prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa among Japanese patients.
    Shimizu H; Suzumori K; Nishikawa T
    Dermatology; 1996; 192(3):203-7. PubMed ID: 8726631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
    J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
    Remington J; Wang X; Hou Y; Zhou H; Burnett J; Muirhead T; Uitto J; Keene DR; Woodley DT; Chen M
    Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.
    Atanasova VS; Russell RJ; Webster TG; Cao Q; Agarwal P; Lim YZ; Krishnan S; Fuentes I; Guttmann-Gruber C; McGrath JA; Salas-Alanis JC; Fertala A; South AP
    J Invest Dermatol; 2019 Jul; 139(7):1497-1505.e5. PubMed ID: 30684555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
    Liao Y; Ivanova L; Sivalenka R; Plumer T; Zhu H; Zhang X; Christiano AM; McGrath JA; Gurney JP; Cairo MS
    Stem Cells Transl Med; 2018 Jul; 7(7):530-542. PubMed ID: 29745997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of severe dystrophic epidermolysis bullosa: overexpression of collagen VII by cutaneous cells from a patient with mutilating disease.
    König A; Winberg JO; Gedde-Dahl T; Bruckner-Tuderman L
    J Invest Dermatol; 1994 Feb; 102(2):155-9. PubMed ID: 8106746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of recessive dystrophic epidermolysis bullosa: genotype/phenotype correlation in a case of moderate clinical severity.
    Shimizu H; McGrath JA; Christiano AM; Nishikawa T; Uitto J
    J Invest Dermatol; 1996 Jan; 106(1):119-24. PubMed ID: 8592061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen.
    van den Akker PC; Mellerio JE; Martinez AE; Liu L; Meijer R; Dopping-Hepenstal PJ; van Essen AJ; Scheffer H; Hofstra RM; McGrath JA; Jonkman MF
    J Med Genet; 2011 Mar; 48(3):160-7. PubMed ID: 21113014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal model for dermolytic mechanobullous disease: sheep with recessive dystrophic epidermolysis bullosa lack collagen VII.
    Bruckner-Tuderman L; Guscetti F; Ehrensperger F
    J Invest Dermatol; 1991 Apr; 96(4):452-8. PubMed ID: 2007783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa.
    Gretzmeier C; Pin D; Kern JS; Chen M; Woodley DT; Bruckner-Tuderman L; de Souza MP; Nyström A
    J Invest Dermatol; 2022 Apr; 142(4):1094-1102.e3. PubMed ID: 34606885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Dunnill MG; McGrath JA; Richards AJ; Christiano AM; Uitto J; Pope FM; Eady RA
    J Invest Dermatol; 1996 Aug; 107(2):171-7. PubMed ID: 8757758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
    Dang N; Klingberg S; Marr P; Murrell DF
    J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type VII collagen and 19-DEJ-1 antigen. Comparison of expression in inversa and generalized variants of recessive dystrophic epidermolysis bullosa.
    Fine JD; Johnson LB; Wright T
    Arch Dermatol; 1990 Dec; 126(12):1587-93. PubMed ID: 2256686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
    Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A
    J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.
    Georgiadis C; Syed F; Petrova A; Abdul-Wahab A; Lwin SM; Farzaneh F; Chan L; Ghani S; Fleck RA; Glover L; McMillan JR; Chen M; Thrasher AJ; McGrath JA; Di WL; Qasim W
    J Invest Dermatol; 2016 Jan; 136(1):284-92. PubMed ID: 26763448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors.
    Baldeschi C; Gache Y; Rattenholl A; Bouillé P; Danos O; Ortonne JP; Bruckner-Tuderman L; Meneguzzi G
    Hum Mol Genet; 2003 Aug; 12(15):1897-905. PubMed ID: 12874109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
    Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
    Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.